See All Slides - tctmd.com

Slides

Presentation TCT 2012

A View from a Small Medical Device Company

Presenter: Stephen Rowland

October 25, 2012

$SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients$

Presentation TCT 2012

SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients

Presenter: Deepak Bhatt

October 25, 2012

Presentation TCT 2012

Complications of Transradial Access

Presenter: Philippe Genereux

October 25, 2012

Presentation TCT 2012

Mitral Valve Bioprosthesis Degeneration with Perivalvular Leak: When One Door Closes, Another Opens

Presenter: Sergio Berti

October 25, 2012

Presentation TCT 2012

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Presenter: Javier Escaned

October 25, 2012

Presentation TCT 2012

Post-EVAR Follow-up and Imaging Surveillance: Current and Future Trends

Presenter: Robert Lookstein

October 25, 2012

Presentation TCT 2012

Can Any IVUS/OCT Parameters Replace FFR?

Presenter: Bon-Kwon Koo

October 25, 2012

Presentation TCT 2012

How I Integrate FFR and IVUS in the Cath Lab and Why

Presenter: Seung-Jung Park

October 25, 2012

Presentation TCT 2012

Case Presentation Conclusion: Procedural and Late Patient Outcomes(2)

Presenter: Miles Dalby

October 25, 2012

Presentation TCT 2012

Defending the TVT Registry as a Mechanism to Facilitate Expansion of TAVR Clinical Indications

Presenter: E. Murat Tuzcu

October 25, 2012

Advertisement

Slides

A View from a Small Medical Device Company

SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients

Complications of Transradial Access

Mitral Valve Bioprosthesis Degeneration with Perivalvular Leak: When One Door Closes, Another Opens

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Post-EVAR Follow-up and Imaging Surveillance: Current and Future Trends

Can Any IVUS/OCT Parameters Replace FFR?

How I Integrate FFR and IVUS in the Cath Lab and Why

Case Presentation Conclusion: Procedural and Late Patient Outcomes(2)

Defending the TVT Registry as a Mechanism to Facilitate Expansion of TAVR Clinical Indications

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content